Skip to Content


In the US, Sacrosidase (sacrosidase systemic) is a member of the drug class digestive enzymes and is used to treat Enzymopathy, Unspecified.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Enzyme replacement therapy

Chemical Name

β - Fructofuranosidase (Saccharomyces cerevisiae clone FI4 protein moiety reduced) (USAN)

Foreign Names

  • Sacrosidasum (Latin)
  • Sacrosidase (German)
  • Sacrosidasa (Spanish)

Generic Names

Brand Names

  • Sucraid
    Excelsior, Taiwan; QOL Medical, United States


ISInofficial Synonym
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.